News Releases

News Releases

October 2, 2018
MeiraGTx to Present at Upcoming Conferences
LONDON and NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it will present at the following conferences: 2018 Cell & Gene Meeting on the Mesa on Thursday, October 4, 2018 at 1:45 p.m.
June 12, 2018
MeiraGTx Announces Closing of Initial Public Offering

LONDON and NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the closing of its initial public offering of 5,000,000 ordinary shares at a public offering price of $15.00 per share.

Displaying 1 - 10 of 14